Trends in cancer incidence and survival in the Augsburg study region-results from the Augsburg cancer registry.
epidemiology
health policy
public health
quality in health care
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
30 08 2020
30 08 2020
Historique:
entrez:
2
9
2020
pubmed:
2
9
2020
medline:
17
2
2021
Statut:
epublish
Résumé
Knowledge about time trends of cancer incidence and cancer survival in a defined region is an essential prerequisite for the planning of regional healthcare infrastructure. The aim of the study was to provide population-based analyses of all common tumour sites to assess the cancer burden in the Augsburg study region. Total population of the study region of Augsburg (668 522 residents), Southern Germany. The data obtained from the Cancer Registry Augsburg comprised 37 487 incident cases of malignant tumours (19 313 men and 18 174 women) diagnosed between 2005 and 2016 in the Augsburg region's resident population. We calculated sex-specific, age-standardised incidence rates and annual percent change to assess time trends. In men and in women, 3-year and 5-year relative survival was calculated and results were compared with the latest German estimates. Survival trends were presented for the most common cancers only. Decreasing age-standardised incidence rates were observed for prostate cancer and for colorectal cancer in men. For oropharyngeal cancer, rates declined in men, but significantly increased in women. Incidence for female breast cancer remained stable. Five-year relative survival ranged between 6.4% (95% CI: 4.1% to 10.1%) for pancreatic cancer and 97.7% (95% CI: 96.0% to 99.4%) for prostate cancer in men and between 10.2% (95% CI: 7.1% to 14.6%) for pancreatic cancer and 96.6% (95% CI: 93.6% to 99.6%) for malignant melanoma in women. Trends in 3-year survival of the five most common tumour sites in men showed a significant increase for lung and oropharyngeal cancer. In women, continuously rising survival trends were observed for breast cancer. Survival of cancer patients in the Augsburg study region was largely concordant with the situation in Germany as a whole, while incidence showed slight deviations in some cancer sites. Regional evaluations on cancer survival are a valuable instrument for identifying deficits and determining advances in oncological health management.
Identifiants
pubmed: 32868355
pii: bmjopen-2019-036176
doi: 10.1136/bmjopen-2019-036176
pmc: PMC7462243
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e036176Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMC Cancer. 2010 Feb 22;10:52
pubmed: 20175882
Eur J Cancer. 2015 Oct;51(15):2104-2119
pubmed: 26421815
Gesundheitswesen. 2010 Oct;72(10):692-9
pubmed: 20049680
J Cancer Res Clin Oncol. 2007 Jan;133(1):23-35
pubmed: 16896882
Ann Oncol. 2012 Feb;23(2):472-9
pubmed: 21597096
Int J Colorectal Dis. 2014 Sep;29(9):1031-42
pubmed: 24953060
Lancet Oncol. 2014 Jan;15(1):23-34
pubmed: 24314615
Eur J Cancer. 2008 Jul;44(10):1345-89
pubmed: 18280139
BMC Cancer. 2006 Jun 27;6:170
pubmed: 16803628
Int J Cancer. 2007 Nov 15;121(10):2274-8
pubmed: 17594692
Int J Cancer. 2009 May 15;124(10):2406-15
pubmed: 19142968
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Jan;61(1):20-31
pubmed: 29181809
Tob Control. 2017 Jul;26(4):455-457
pubmed: 27377343
Lung Cancer. 2015 Dec;90(3):528-33
pubmed: 26480866
Int J Cancer. 2012 Oct 1;131(7):1649-58
pubmed: 21607946
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Dtsch Arztebl Int. 2016 Feb 19;113(7):101-6
pubmed: 26940777
Sci Rep. 2018 Aug 10;8(1):11981
pubmed: 30097633
Eur J Cancer Prev. 2019 May;28(3):234-242
pubmed: 29672354
Br J Cancer. 1996 Apr;73(7):955-60
pubmed: 8611414
Gesundheitswesen. 2016 Feb;78(2):84-90
pubmed: 26906532
Int J Cancer. 2003 Sep 1;106(3):416-22
pubmed: 12845683
Int J Cancer. 2015 Jun 1;136(11):2649-58
pubmed: 25380088
Cancer Epidemiol. 2014 Jun;38(3):259-65
pubmed: 24680643
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Nov;61(11):1365-1376
pubmed: 30215104
Cancer Epidemiol. 2016 Oct;44:44-51
pubmed: 27470937
Gesundheitswesen. 2013 Feb;75(2):94-8
pubmed: 22581626
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
Natl Cancer Inst Monogr. 1961 Sep;6:101-21
pubmed: 13889176
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Sep;61(9):1170-1186
pubmed: 30167729